Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Mujie YeJinhao ChenFeiyu LuMinghui ZhaoSuwen WuChunhua HuPing YuJingbao KanJianan BaiYe TianQiyun TangPublished in: Cell & bioscience (2023)
In conclusion, our study revealed the FTO-ALKBH5/IGF2BP2/HK2/FOXO1 axis as a mechanism of aberrant m6A modification and glycolysis regulation in CRC.